<DOC>
	<DOCNO>NCT02609620</DOCNO>
	<brief_summary>This study designate test safety initial efficacy LunGuard 's PFT device reduction GER . Enterally-Fed , Sedated Mechanically Ventilated Critically Ill Patients ICU PFT position use feed Nutritional Formula.Samples take suction predetermine interval analyse Pepsin A concentration . The PFT remove upon completion study 's schedule routine . Patients control group standard polyurethane nasogastric device insert accord standard procedure , consider gold standard .</brief_summary>
	<brief_title>Safety &amp; Initial Efficacy LunGuard PFT Sys . Enteral-Fed , Sedated Mechanically Ventilated Patients Peristaltic Feeding Tube</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Informed consent . Patients expect least 12 hour : Mechanically ventilate sedate . Requiring nasogastric tube . Included : Patients undergone tracheostomy . Patients require use prokinetic drug proton pump inhibitor . All level Gastric Residual Volume ( GRV ) â€¢ Patients contraindication insertion nasogastric tube . Patients know esophageal obstruction , prevent passage device . Esophageal disease include : achalasia , hiatal hernia anatomical anomaly and/or esophageal pathology , esophagitis , Zenkers diverticulum , paraesophageal hernia , esophageal varix . ( excluded minor GERD patient ) Acute severe coagulation disorder ( INR &gt; 2 platelet 30,000 ) Diabetic patient document gastrointestinal neuropathy Pregnancy lactation Allergy Silicon Patients currently enrol another clinical investigation intervention might compromise safety patient 's participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>